Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 608104, 6 pages
http://dx.doi.org/10.1155/2014/608104
Research Article

A Pilot Study Evaluating the Contribution of SLC19A1 (RFC-1) 80G>A Polymorphism to Alzheimer’s Disease in Italian Caucasians

1Division of Medical Genetics, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Medical School, Via Roma 56, 56126 Pisa, Italy
2Unit of Neurology, Department of Neuroscience, Pisa University Hospital, Via Roma 67, 56126 Pisa, Italy
3Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy
4Unit of Neurorehabilitation, Department of Neuroscience, Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy
5Department of Clinical and Experimental Medicine, University of Pisa, Neurological Clinic, Via Roma 67, 56126 Pisa, Italy

Received 27 February 2014; Revised 16 May 2014; Accepted 26 May 2014; Published 5 June 2014

Academic Editor: Paolo Villari

Copyright © 2014 Fabio Coppedè et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Sosa-Ortiz, I. Acosta-Castillo, and M. J. Prince, “Epidemiology of dementias and Alzheimer's disease,” Archives of Medical Research, vol. 43, no. 8, pp. 600–608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Coppedè, “One-carbon metabolism and Alzheimer's disease: focus on Epigenetics,” Current Genomics, vol. 11, no. 4, pp. 246–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Regland, L. Abrahamsson, C. G. Gottfries, and E. Magnus, “Vitamin B12 analogues, homocysteine, methylmalonic acid, and transcobalamins in the study of vitamin B12 deficiency in primary degenerative dementia,” Dementia, vol. 1, no. 5, pp. 272–277, 1990. View at Google Scholar · View at Scopus
  4. P. Quadri, C. Fragiacomo, R. Pezzati et al., “Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia,” The American Journal of Clinical Nutrition, vol. 80, no. 1, pp. 114–122, 2004. View at Google Scholar · View at Scopus
  5. N. G. Faux, K. A. Ellis, L. Porter et al., “Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: Baseline characteristics in subjects of the australian imaging biomarker lifestyle study,” Journal of Alzheimer's Disease, vol. 27, no. 4, pp. 909–922, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Coppedè, P. Tannorella, I. Pezzini et al., “Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls,” Antioxidants and Redox Signaling, vol. 17, no. 2, pp. 195–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. S. Wald, A. Kasturiratne, and M. Simmonds, “Serum homocysteine and dementia: Meta-analysis of eight cohort studies including 8669 participants,” Alzheimer's and Dementia, vol. 7, no. 4, pp. 412–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-M. Zhuo, H. Wang, and D. Praticò, “Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?” Trends in Pharmacological Sciences, vol. 32, no. 9, pp. 562–571, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. van Dam and W. A. van Gool, “Hyperhomocysteinemia and Alzheimer's disease: a systematic review,” Archives of Gerontology and Geriatrics, vol. 48, no. 3, pp. 425–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hinterberger and P. Fischer, “Folate and alzheimer: when time matters,” Journal of Neural Transmission, vol. 120, no. 1, pp. 211–224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Moore, A. Mander, D. Ames, R. Carne, K. Sanders, and D. Watters, “Cognitive impairment and vitamin B12: a review,” International Psychogeriatrics, vol. 24, no. 4, pp. 541–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Cacciapuoti, “Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease,” Journal of Thrombosis and Thrombolysis, vol. 36, no. 3, pp. 258–262, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. Naj, G. W. Beecham, E. R. Martin et al., “Dementia revealed: novel chromosome 6 locus for Late-onset alzheimer disease provides genetic evidence for folate-pathway abnormalities,” PLoS Genetics, vol. 6, no. 9, Article ID e1001130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Hua, H. Zhao, Y. Kong, and M. Ye, “Association between the MTHFR gene and Alzheimer's disease: a meta-analysis,” International Journal of Neuroscience, vol. 121, no. 8, pp. 462–471, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. X. H. Bi, H. L. Zhao, Z. X. Zhang, and J. W. Zhang, “Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease,” Neurobiology of Aging, vol. 30, no. 10, pp. 1601–1607, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kageyama, M. Hiraoka, and Y. Kagawa, “Relationship between genetic polymorphism, serum folate and homocysteine in Alzheimer's disease,” Asia-Pacific Journal of Public Health, vol. 20, pp. 111–117, 2008. View at Google Scholar · View at Scopus
  17. R. Zhao, L. H. Matherly, and I. D. Goldman, “Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues,” Expert Reviews in Molecular Medicine, vol. 11, article e4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Chango, N. Emery-Fillon, G. P. De Courcy et al., “A polymorphism (80G>A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia,” Molecular Genetics and Metabolism, vol. 70, no. 4, pp. 310–315, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Eklöf, B. Van Guelpen, J. Hultdin, I. Johansson, G. Hallmans, and R. Palmqvist, “The reduced folate carrier (RFC1) 80G>A and folate hydrolase 1 (FOLH1) 1561C>T polymorphisms and the risk of colorectal cancer: a nested case-referent study,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 68, no. 5, pp. 393–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Stanisławska-Sachadyn, L. E. Mitchell, J. V. Woodside et al., “The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell folate concentrations among women,” Annals of Human Genetics, vol. 73, no. 5, pp. 484–491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Mansoori, M. Tripathi, R. Alam et al., “Serum folic acid and RFC A80G polymorphism in Alzheimer's disease and Vascular Dementia,” The American Journal of Alzheimer's Disease & Other Dementias, vol. 29, no. 1, pp. 38–44, 2014. View at Google Scholar
  22. M. Białecka, M. Kurzawski, A. Roszmann et al., “Association of COMT, MTHFR, and SLC19A1 (RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease,” Pharmacogenetics and Genomics, vol. 22, no. 10, pp. 716–724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. The Dementia Study Group of the Italian Neurological Society, “Guidelines for the diagnosis of dementia and Alzheimer's disease,” Neurological Sciences, vol. 21, pp. 187–194, 2000. View at Google Scholar
  24. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 4th edition, 1994.
  25. F. Coppedè, G. Marini, S. Bargagna et al., “Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women,” The American Journal of Medical Genetics, vol. 140, no. 10, pp. 1083–1091, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Coppedè, E. Grossi, M. Buscema, and L. Migliore, “Application of artificial neural networks to investigate one-carbon metabolism in Alzheimer's disease and healthy matched individuals,” PLoS ONE, vol. 8, no. 8, Article ID e74012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Kumudini, A. Uma, S. M. Naushad, R. Mridula, R. Borgohain, and V. K. Kutala, “Association of seven functional polymorphisms of one-carbon metabolic pathway with total plasma homocysteine levels and susceptibility to Parkinson's disease among South Indians,” Neuroscience Letters, vol. 568, pp. 1–5, 2014. View at Google Scholar
  28. S. S. Wang, C. Wang, F. Y. Qiao, J. J. Lv, and L. Feng, “Polymorphisms in genes RFC-1/CBS as maternal risk factors for Down syndrome in China,” Archives of Gynecology and Obstetrics, vol. 288, no. 2, pp. 273–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Costa-Lima, M. R. Amorim, and I. M. Orioli, “Association of methylenetetrahydrofolate reductase gene 677C>T polymorphism and Down syndrome,” Molecular Biology Reports, vol. 40, no. 3, pp. 2115–2125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Dhillon, P. Thomas, and M. Fenech, “Effect of common polymorphisms in folate uptake and metabolism genes on frequency of micronucleated lymphocytes in a South Australian cohort,” Mutation Research, vol. 665, no. 1-2, pp. 1–6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Coppedè, R. Colognato, A. Bonelli et al., “Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children,” The American Journal of Medical Genetics A, vol. 143, no. 17, pp. 2006–2015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Reitz, G. Jun, A. Naj et al., “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein e ε4, and the risk of late-onset Alzheimer disease in African Americans,” Journal of the American Medical Association, vol. 309, no. 14, pp. 1483–1492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Gallucci, A. Zanardo, M. Bendini, F. Di Paola, P. Boldrini, and E. Grossi, “Serum folate, homocysteine, brain Atrophy, and auto-CM system: the treviso dementia (TREDEM) Study,” Journal of Alzheimer's Disease, vol. 38, no. 3, pp. 581–587, 2014. View at Google Scholar
  34. M. Hinterberger, S. Zehetmayer, S. Jungwirth et al., “High cortisol and low folate are the only routine blood tests predicting probable alzheimer's disease after age 75 - Results of the vienna transdanube aging study,” Journal of the American Geriatrics Society, vol. 61, no. 4, pp. 648–651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Hu, L. Wu, J. Jia, and Y. Han, “Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques,” Neuroscience Bulletin, vol. 30, no. 2, pp. 198–206, 2014. View at Google Scholar
  36. A. M. Devlin, R. Clarke, J. Birks, J. G. Evans, and C. H. Halsted, “Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population,” The American Journal of Clinical Nutrition, vol. 83, no. 3, pp. 708–713, 2006. View at Google Scholar · View at Scopus